{"concreteType":"org.sagebionetworks.repo.model.table.QueryResultBundle","queryResult":{"concreteType":"org.sagebionetworks.repo.model.table.QueryResult","queryResults":{"concreteType":"org.sagebionetworks.repo.model.table.RowSet","tableId":"syn16859580","etag":"f9059731-050f-4d1c-be6c-46b69657cdc2","headers":[{"name":"id","columnType":"ENTITYID","id":"2510"},{"name":"datasetName","columnType":"LARGETEXT","id":"70044"},{"name":"diseaseFocus","columnType":"STRING","id":"56918"},{"name":"tumorType","columnType":"STRING","id":"39539"},{"name":"summary","columnType":"LARGETEXT","id":"69194"},{"name":"fundingAgency","columnType":"STRING","id":"38862"},{"name":"fileCount","columnType":"INTEGER","id":"70045"},{"name":"fileSize","columnType":"INTEGER","id":"31167"},{"name":"featured","columnType":"STRING","id":"71578"}],"rows":[{"rowId":0,"versionNumber":20,"values":["syn16812247","Synodos NF2 RNASeq (Processed)","Neurofibromatosis 2","Schwannoma | Meningioma","This set contains counts-level and differential expression data files for NF2 schwannoma and meningioma models that were treated with vehicle control or HDAC, PI3K, and mTOR inhibitors. ","CTF","13","45893643","yes"]},{"rowId":2,"versionNumber":20,"values":["syn16815073","pNF Cell Line Single Agent Drug Screening","Neurofibromatosis 1","Plexiform Neurofibroma","This set contains processed high-throughput single-agent drug screening data for pNF cells treated with the NCATS MIPE 4.0 library. ","NTAP","55","3474326","yes"]},{"rowId":6,"versionNumber":20,"values":["syn17018076","Plexiform Neurofibroma Interactome","Neurofibromatosis 1","Plexiform Neurofibroma","This set contains the raw microarray data for both plexiform cells and neighboring macrophages to determine the effect of the microenvironment on pNF growth.","NTAP","50","768989906","yes"]},{"rowId":10,"versionNumber":23,"values":["syn17095981","Columbia LGG Glioma Data","Neurofibromatosis 1","Low Grade Glioma | High Grade Gliom","Neurofibromatosis type 1 (NF1) is a common tumor predisposition syndrome in which glioma is one of the prevalent tumors. Gliomagenesis in NF1 results in a heterogeneous spectrum of low- to high-grade neoplasms occurring during the entire lifes- pan of patients. The pattern of genetic and epigenetic alterations of glioma that develops in NF1 patients and the similarities with sporadic glioma remain unknown. Here, we present the molecular landscape of low- and high-grade gliomas in patients affected by NF1 (NF1-glioma). We found that the predisposing germline mutation of the NF1 gene was frequently converted to homozygosity and the somatic mutational load of NF1-glioma was influenced by age and grade.","CTF","224","2681351317","yes"]}]}},"selectColumns":[{"name":"id","columnType":"ENTITYID","id":"2510"},{"name":"datasetName","columnType":"LARGETEXT","id":"70044"},{"name":"diseaseFocus","columnType":"STRING","id":"56918"},{"name":"tumorType","columnType":"STRING","id":"39539"},{"name":"summary","columnType":"LARGETEXT","id":"69194"},{"name":"fundingAgency","columnType":"STRING","id":"38862"},{"name":"fileCount","columnType":"INTEGER","id":"70045"},{"name":"fileSize","columnType":"INTEGER","id":"31167"},{"name":"featured","columnType":"STRING","id":"71578"}],"columnModels":[{"id":"2510","name":"id","columnType":"ENTITYID"},{"id":"70044","name":"datasetName","columnType":"LARGETEXT"},{"id":"56918","name":"diseaseFocus","columnType":"STRING","maximumSize":50,"facetType":"enumeration"},{"id":"39539","name":"tumorType","columnType":"STRING","maximumSize":50,"facetType":"enumeration"},{"id":"69194","name":"summary","columnType":"LARGETEXT"},{"id":"38862","name":"fundingAgency","columnType":"STRING","maximumSize":50,"facetType":"enumeration"},{"id":"70045","name":"fileCount","columnType":"INTEGER"},{"id":"31167","name":"fileSize","columnType":"INTEGER"},{"id":"71578","name":"featured","columnType":"STRING","maximumSize":3,"enumValues":["yes"]}],"facets":[{"concreteType":"org.sagebionetworks.repo.model.table.FacetColumnResultValues","columnName":"diseaseFocus","facetType":"enumeration","facetValues":[{"value":"Neurofibromatosis 1","count":3,"isSelected":false},{"value":"Neurofibromatosis 2","count":1,"isSelected":false}]},{"concreteType":"org.sagebionetworks.repo.model.table.FacetColumnResultValues","columnName":"tumorType","facetType":"enumeration","facetValues":[{"value":"Low Grade Glioma | High Grade Gliom","count":1,"isSelected":false},{"value":"Plexiform Neurofibroma","count":2,"isSelected":false},{"value":"Schwannoma | Meningioma","count":1,"isSelected":false}]},{"concreteType":"org.sagebionetworks.repo.model.table.FacetColumnResultValues","columnName":"fundingAgency","facetType":"enumeration","facetValues":[{"value":"CTF","count":2,"isSelected":false},{"value":"NTAP","count":2,"isSelected":false}]}]}